ArticleWorld journal of diabetes2022

Immediate-release tofacitinib reduces insulin resistance in non-diabetic active rheumatoid arthritis patients: A single-center retrospective study.

Chrong-Reen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.